Aptose Biosciences

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research, and development of novel first-in-class cancer therapies with high safety profiles. Through its own discovery efforts and collaborative activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinically proven stages. Our pipeline includes products designed to provide single-agent efficacy and enhance the efficacy of traditional anticancer therapies by simultaneously targeting key drivers of the disease in cancer cells without overlapping toxicities, thereby preserving the quality of life for cancer patients.